BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...
In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.
A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the ...
“Illumina has been supporting India for over a decade by providing access to genomic sequencing technologies, in particular next-generation sequencing, and building our presence and capability ...
(Bloomberg) -- Illumina Inc.’s blocked $7 billion takeover of cancer-detection provider Grail Inc. should never have been probed by the European Union, according to a top court ruling that ...
(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...
He added Illumina has been supporting India for over a decade by providing access to genomic sequencing technologies, in particular next-generation sequencing, and therefore building its presence ...
Illumina has secured an FDA approval to bring its pan-cancer tissue profiling test to U.S. shores. A version of the company’s TruSight Oncology Comprehensive genomic diagnostic kit has been ...
Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...
Put them up on a wall or whiteboard or lay them across a table. Post-it notes are preferable at this stage as they allow the design team to easily stick up and move pieces of data around to cluster ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈